Latinoamérica: en busca del mejor modelo predictivo de recurrencia del hepatocarcinoma después del trasplante
Federico Piñero, Aline Chagas, e ilka Boin – 29 May 2019
Federico Piñero, Aline Chagas, e ilka Boin – 29 May 2019
Jianbo He, Jingying Chen, Xiangyong Wei, Hui Leng, Hongliang Mu, Pengcheng Cai, Lingfei Luo – 28 May 2019 – The liver has a high regenerative capacity. Upon two‐thirds partial hepatectomy, the hepatocytes proliferate and contribute to liver regeneration. After severe liver injury, when the proliferation of residual hepatocytes is blocked, the biliary epithelial cells (BECs) lose their morphology and express hepatoblast and endoderm markers, dedifferentiate into bipotential progenitor cells (BP‐PCs), then proliferate and redifferentiate into mature hepatocytes.
Nayantara Orekondy, John Cafardi, Tatyana Kushner, Nancy Reau – 28 May 2019
Jody Dushay, Michelle Lai – 28 May 2019
Nayantara Orekondy, John Cafardi, Tatyana Kushner, Nancy Reau – 28 May 2019
Reinout L.P. Roscam Abbing, Davor Slijepcevic, Joanne M. Donkers, Rick Havinga, Suzanne Duijst, Coen C. Paulusma, Johan Kuiper, Folkert Kuipers, Albert K. Groen, Ronald P.J. Oude Elferink, Stan F.J. Graaf – 28 May 2019 – Active secretion of bile salts into the canalicular lumen drives bile formation and promotes biliary cholesterol and phospholipid output. Disrupting hepatic bile salt uptake, by inhibition of sodium‐taurocholate cotransporting polypetide (NTCP; Slc10a1) with Myrcludex B, is expected to limit bile salt flux through the liver and thereby to decrease biliary lipid excretion.
Benedetta Terziroli Beretta‐Piccoli, Richard Thompson, Pierre Foskett, Andreas Cerny, Elisabetta Merlo, Diego Vergani, Anne‐Laure Rougemont, Isabelle Moix, Giorgina Mieli‐Vergani, Michael Morris – 24 May 2019
Rosalie C. Oey, Manon C. W. Spaander, Henk R. Buuren, Robert A. Man – 24 May 2019
Xing Lai, Junhua Gong, Weiming Wang, Ding Cao, Menghao Wang, Yiming Liu, Hao Wu, Yakun Wu, Yong Chen, Zhong Zeng, Jinzheng Li, Jianping Gong – 24 May 2019 – In liver transplant cases, severe hepatic ischemia/reperfusion injury (HIRI) is a strong predictor of adverse liver graft and overall outcomes. During HIRI, high‐mobility group box 1 (HMGB1) promotes hepatocellular death and proinflammatory cytokine secretion by toll‐like receptor 4 (TLR4).
Benedetta Terziroli Beretta‐Piccoli, Richard Thompson, Pierre Foskett, Andreas Cerny, Elisabetta Merlo, Diego Vergani, Anne‐Laure Rougemont, Isabelle Moix, Giorgina Mieli‐Vergani, Michael Morris – 24 May 2019